retatrutide weight loss results clinical trial Shines in Obesity with 65lb | Zhonghao (John) Liu posted on the topic A new clinical trial from

The GLP-1 boom spearheaded by Novo Nordisk and Eli Lilly has already reshaped how millions of people think about obesity, diabetes, and food

Besides, there is growing interest in its application in neurobiology, especially in the treatment of some neurodegenerative disorders like Parkinsons and Alzheimers, because of its capacity to reduce oxidative stress in the neurons

Sound too good to be true

The CNS also contains reward systems that influence motivational processes related to eating behaviour

NeuroReport 25(10):763-767. [doi.org]

Hims stock price experienced a significant drop, reflecting the markets growing skepticism about a model that was never built to last